SEPTIN14P17

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, SEPTIN14P17 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of SEPTIN14P17’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where SEPTIN14P17 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SEPTIN14P17 is over-expressed in tumor.

PRAD are the cancer types where SEPTIN14P17 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SEPTIN14P17 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
PRADAllAll+0.035.0492view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

SEPTIN14P17–PRAD

Tumor-vs-normal expression box plot for SEPTIN14P17 RNA in PRAD.

Open the PRAD breakdown →

Exploration